Industry News
We at AOP understand the challenges orthopedic surgeons face every day and we’re here to stand beside you – uniting the best in private orthopedic practice with the advantages of collaboration.
© 2024 American Orthopedic Partners, Inc. All rights reserved.
AOP Response: We have high hopes that advanced drug and gene/immune therapies will lead to revolutionary advancements. Unfortunately, currently, many of these therapies are limited by the FDA for use in the US. Many regenerative technologies are approved for treatment outside the US and in veterinary medicine, and we are staying abreast of the associated research. But the cost remains prohibitive, and questions endure about whether stem cells should be a standalone therapy or a complement to traditional orthopedic practices. AOP anticipates being an early adopter once biologics/cellular therapies are allowed more broadly in the US.
We’re thrilled to congratulate Dr. Thomas Dwyer of Premier Orthopaedic Associates, a valued AOP partner, on being honored with the prestigious Castle Connolly TOP Doc Award again for 2024!
Sorry, the comment form is closed at this time.